BIOMATERIALS

BIOMATERIALS AND NEW MATERIALS

Biomaterials have revolutionized areas like bioengineering, diagnostics, and tissue engineering for the development of novel strategies to combat life threatening diseases. Biomaterials are now widely used in healthcare fields such as cardiology, orthopedics, dentistry, ophthalmology, oncology, neurology, plastic medical procedure, and wound repair. Furthermore, they are utilized in different advanced healthcare technologies such as cosmetic surgeries, tissue engineering, medical implants, and advanced drug delivery. The growth potential of this industry is vast; globally, the biomaterial market size is expected to reach $250.4 billion USD by 2025. A dynamic group of researchers at Dalhousie, from across a variety of disciplines, have come together to make the remarkable biomaterials research team. At the heart of this program is a desire to use sound materials science engineering principles and unique processing strategies to optimize the biological performance of materials destined for clinical applications. This approach is by necessity a multidisciplinary one, as it requires an additional working knowledge of cell behavior and biological processes along with substantial engagement with the clinical community. With a vision of utilizing the body's own powers of regeneration while creating personalized and minimally invasive treatment solutions, Dalhousie's biomaterials researchers are on the forefront of this rapidly expanding area of research. This team’s mission: get breakthrough technologies to patients in need.

“Imagine a grandparent or parent who has been diagnosed with metastatic colorectal cancer or primary liver cancer. Imagine that loved-one having to receive radiotherapy that might damage some of their organs or chemotherapy that makes them very unwell; for most people, these painful and stressful treatment options are the only options available to fight this critical disease. Our biomaterials team are developing solutions that will selectively treat some cancers from inside the tumour, ameliorating the condition so our loved-ones don't have to feel some of those long term and systemic effects that can reduce our quality of life.  Instead, these patients could have outpatient procedures where pain and illness is reduced by using glass technologies. The potential for these technologies is enormous, branching out beyond oncology and through to oral health and pain management from osteoarthritis.”

- Dr. Daniel Boyd
Research Team Lead & Associate Professor, Department of Diagnostic Radiology, Faculty of Dentistry, School of Biomedical Engineering, Dalhousie University